Human cell lines resistant to N-methyl-N-nitrosourea (MNU) were previo
usly assigned to two complementation groups. Members of group I are de
fective in mismatch correction [S. Ceccotti, G. Aquilina, P. Macpherso
n, M. Yamada, P. Karran, M. Bignami, Processing of O-6-methylguanine b
y mismatch correction in human cell extracts. Current Biol. 6 (1996) 1
528-1531]. To identify the mechanism responsible for the less pronounc
ed phenotype of the second complementation group, we characterized the
persistence of MNU-induced O-6-methylguanine (O-6-meGua) and mutation
induction at the hypoxanthine guanine phosphoribosyl-transferase (HPR
T) locus. Group II clones are unable to repair the premutagenic base O
-6-meGua and are as mutable by MNU as group I clones and the parental
HeLaMR cells. MNU-induced SCE were undetectable in group I clones and
drastically reduced in group II in comparison with the parental cells.
These observations are consistent with a defective processing of DNA
methylation damage by members of both groups. Group II clones exhibit
a moderate spontaneous mutator phenotype at the HPRT gene but signific
ant instability at mononucleotide repeat microsatellites. Introduction
of a single human chromosome 2 (but not of chromosome 3 or 7) into gr
oup II cells partially reverts both MNU resistance and the increased s
pontaneous mutation rate. The properties of group II variants are cons
istent with methylation tolerance and a partially defective mismatch r
epair. We propose that members of group II are defective in the chromo
some 2-based mismatch correction gene GTBP/hMSH6. (C) 1997 Elsevier Sc
ience B.V.